WallSt Focus

Tech player, PagerDuty has entered the spotlight due to a Bloomberg report that unveiled the company's consultation with advisers over a possible sale.

So far, January has been a challenging month for Wall Street, and today was no exception, with investor confidence drooping due to dimming hope of rate interest cuts.

January’s performance so far has been a rollercoaster ride filled with ups and downs. Last week’s turnaround has spurred investor confidence and begs the question: What comes next?

Clinical stage biopharma small-cap, Harpoon Therapeutics has entered the spotlight with pharma giant, Merck agreeing to acquire the company for a staggering $680 million.

December's Consumer Price Index (CPI) data is in, and it brought a mixed bag of news for investors and consumers alike. While headline inflation ticked up slightly to 3.4%, exceeding most analysts' expectations, the core inflation rate held steady at 3.9%.

The first-ever U.S. spot bitcoin ETFs began trading on Thursday, January 11th, 2024, marking a long-awaited milestone for the cryptocurrency industry and sparking a frenzy of excitement as well as apprehension among investors.

In a groundbreaking move, pharmaceutical giant Johnson & Johnson has set the stage for a significant leap forward in cancer treatment with its recent $2 billion acquisition of Ambrx Biopharma.